Fin Trust Capital Advisors, LLC Corcept Therapeutics Inc Transaction History
Fin Trust Capital Advisors, LLC
- $577 Million
- Q3 2024
A detailed history of Fin Trust Capital Advisors, LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Fin Trust Capital Advisors, LLC holds 1,339 shares of CORT stock, worth $106,410. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,339
Previous 1,771
24.39%
Holding current value
$106,410
Previous $57,000
7.02%
% of portfolio
0.01%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding CORT
# of Institutions
470Shares Held
83.2MCall Options Held
489KPut Options Held
1.02M-
Black Rock Inc. New York, NY16.5MShares$1.31 Billion0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.68MShares$769 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY7.72MShares$614 Million20.11% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.27MShares$498 Million0.65% of portfolio
-
Parallel Advisors, LLC3.87MShares$308 Million5.83% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $8.51B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...